Pulse Biosciences, Inc. (PLSE )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PLSE
- Company Pulse Biosciences, Inc.
- Price $20.75
- Changes Percentage 51.57
- Change 7.06
- Day Low $14.95
- Day High $20.78
- Year High $22.75
- Year Low $12.56
- Market Cap $1,406,177,244
- Price Avg 50 EMA (D) $14.25
- Price Avg 200 EMA (D) $15.79
- Exchange NASDAQ
- Volume 2,796,875
- Average Volume 228,642
- Open $14.95
- Previous Close $13.69
- EPS -1.14
- PE -18.20
- Earnings Announcement 2026-02-19 21:00:00
- Shares Outstanding $67,767,578
Company brief: PULSE BIOSCIENCES, INC. (PLSE )
- Healthcare
- Medical - Instruments & Supplies
- Mr. Robert W. Duggan
- https://www.pulsebiosciences.com
- US
- N/A
- 05-18-2016
- US74587B1017
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
PLSE Corporation News
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – Here’s Why
defenseworld.net -- Pulse Biosciences, Inc (NASDAQ: PLSE - Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $13.69, but opened at $14.95. Pulse Biosciences shares last tra...